Concepedia

Author

David S. Snyder

City Of Hope National Medical Center

Also Known As

D S Snyder, D Snyder, D. S. Snyder, D. STEPHEN SNYDER, D. Snyder, D. Stephen Snyder, D.S Snyder, D.S. Snyder, DAVID S. SNYDER, David S Snyder

274

Publications

11.4K

Citations

56

H-Index

158

Concepts

All Affiliations

City Of Hope National Medical CenterCity of HopeThe University of Texas MD Anderson Cancer CenterKaiser PermanenteMemorial Sloan Kettering Cancer Center
DS

About

David S. Snyder is an author at City Of Hope National Medical Center specializing in medicine, hematology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

35

59

4.7K

2

Health Sciences

13

15

847

3

Natural Sciences

3

3

153

4

Education

1

1

25

5

Engineering

1

1

10

David S. Snyder

×

121

Publications

10.4K

Citations

54

H-Index

YearCitations

Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production.

David S. Snyder, Emil R. Unanue

The Journal of Immunology

1982

654

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

Ravi Bhatia, Melissa Holtz, Ning Niu,

Blood

2003

540

Prostaglandins modulate macrophage Ia expression

David S. Snyder, D I Beller, Emil R. Unanue

Nature

1982

540

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

Liton Francisco, Andrea Carter, Can-Lan Sun,

Blood

2007

528

Solid Cancers After Bone Marrow Transplantation

Andrew D. Louie, Ravi Bhatia, Margaret O’Donnell,

Journal of Clinical Oncology

2001

313

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors

Amrita Krishnan, Marilyn L. Slovak, Daniel A. Arber,

Blood

2000

289

Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

Jerald P. Radich, Michael W. Deininger, Camille N. Abboud,

Journal of the National Comprehensive Cancer Network

2018

281

Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Michael W. Deininger, Neil P. Shah, Jessica K. Altman,

Journal of the National Comprehensive Cancer Network

2020

264

Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease

Nelson J. Chao, G. Schmidt, Joyce C. Niland,

New England Journal of Medicine

1993

262

Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate

Bin Zhang, Adam C. Strauss, Su Chu,

Cancer Cell

2010

253

Page 1